4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-22-000102
Chief Financial Officer bought 36,215 shares at $0.97 ($35,129)
From the SEC's structured data for this filing
Trades in this filing
Dhingra Ankur · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-16 | Purchase : show line 1 in the form | +11,557 | $0.97 | $11,210 | 38,057 | D |
| 2022-08-16 | Purchase : show line 2 in the form | +24,658 | $0.97 | $23,918 | 38,196 | I |
| Open-market purchases · 36,215 sh · avg $0.97 · $35,129 | ||||||
Loading xslF345X03/wf-form4_166076931714249.xml…